Celldex Therapeutics Inc (CLDX): Total Asset Value of Company
Celldex Therapeutics (CLDX) focuses on developing breakthrough therapies for severe allergies and inflammation, finalizing preparations for KIT inhibitor trials. Its high authority in targeted antibodies for cancer treatment confirms its scientific standing. The company's price evolution, with total assets at 737.37, links these achievements to the market. Growth potential relies on demand from patients with autoimmune pathologies and future insurance payouts.
Comprehensive metric breakdowns and analytics for Celldex (CLDX)
- price and consensus price forecast:
- market capitalization data:
- book capitalization data:
- debt and liquidity data:
All Debt to Shareholders' Equity Ratio Celldex Therapeutics|CLDX - Long-Term Debt to Equity|Short-Term Debt to Equity Ratio Celldex Corp|CLDX - Company Aggregate Debts|Debts to Book Capitalization Celldex Corp|CLDX - Company Long-Term Liabilities|Company Short-Term Loans and Borrowings Celldex Therapeutics
Fundamental valuation:CLDX, celldex.com
The development of monoclonal antibodies and the optimization of clinical logistics at Celldex Therapeutics (CLDX) require significant resource allocation to maintain high program margins. The dynamics of gross assets, reverse-calculated via ROA, reflect the total value of assets and liabilities, allowing investors to assess capital management efficiency and the risk of liquidity gaps when expanding the balance sheet through borrowed funds.
Competitors of Celldex Therapeutics (CLDX)
ARGX (argenx.com) - Total Business Assets|Aggregate Company Assets BioNTech BNTX|Total Asset Value of Company Abivax|ADMA Bio (ADMA) - Company Total Assets|Aggregate Asset Value Protagonist Corp (PTGX)|Company Total Assets IMVT (Immunovant, Inc.)|kiniksa.com - Company Total Assets|Aggregate Company Assets Grifols (GRFS)|ADPT: Aggregate Asset Value|AUPH (Aurinia Pharma) - Aggregate Company Assets|BioCryst Corp (BCRX) - Cumulative Company Assets|VERA (Vera Therapeutics, Inc.) - Company Total Assets|Company Total Assets dianthustx.com (DNTH)|Pharvaris (PHVS) - Cumulative Company Assets|Aggregate Asset Value AbCellera Biologics (ABCL)|Company Total Assets TRML|Precigen Corp - Company Total Asset Base|PHAR: Aggregate Company Assets|NKTR: Cumulative Company Assets|UPB (Upstream Bio) - Aggregate Company Assets|Cumulative Company Assets Zenas Bio|IMNM (Immunome Corp) - Cumulative Company Assets|Company Total Assets GOSS|Aggregate Company Assets KalVista Pharmaceuticals KALV|Total Business Assets septerna.com (SEPN)|PVLA: Company Total Assets|Company Assets Savara Inc SVRA|RIGL: Company Total Assets|ANAB - Cumulative Company Assets|Company Total Assets ATXS|ENGN (engene.com) - Company Assets|Aggregate Company Assets RAPT Therapeutics|Aggregate Company Assets JBIO|Aggregate Company Assets Aclaris (ACRS)|Aggregate Company Assets Kyverna Therapeutics, Inc (KYTX)|TLSA - Company Total Assets|Total Business Assets cabalettabio.com CABA|VTYX (Ventyx Biosciences, Inc.) - Company Total Assets|Theratechnologies, Inc. (THTX) - Company Assets|Cumulative Company Assets Avalo Therapeutics Inc.|Total Business Assets Eledon Pharmaceuticals, Inc|AGEN - Cumulative Company Assets|Aggregate Asset Value climbbio.com (CLYM)|Cumulative Company Assets Zura Bio|Aggregate Business Assets aTyr Pharma Inc (ATYR)|Company Total Assets Adagene Inc.|Aggregate Asset Value ImageneBio IMA|STTK (Shattuck Therapeutics) - Company Total Assets|EQ: Company Assets|Aggregate Company Assets connectbiopharm.com CNTB|Immunic (IMUX) - Aggregate Asset Value|ATRA (Atara Biotherapeutics, Inc.) - Company Total Assets|Company Total Assets IFRX|XFOR - Aggregate Company Assets|Total Asset Value of Company adicetbio.com (ACET)|CELU: Company Total Assets|INMB - Company Assets|Barinthus Bio - Cumulative Company Assets|Kezar Life Sciences Inc (KZR) - Company Total Assets|SABS - Cumulative Company Assets|akaritx.com (AKTX) - Aggregate Business Assets|ENLV: Company Total Assets|Company Total Asset Base Q32 Bio Corp|Company Total Assets GOVX (GeoVax Labs Inc)|Cumulative Company Assets EDSA (Edesa Biotech Corp)|Aggregate Company Assets IBIO|Company Total Asset Base Carisma Therapeutics Inc CARM|XTLB: Company Total Assets|BOLT: Cumulative Company Assets|hcwbiologics.com (HCWB) - Aggregate Company Assets|Aptevo Therapeutics Inc. (APVO) - Aggregate Company Assets|Company Total Assets AIM ImmunoTech Inc. (AIM)|Total Business Assets Aditxt Corp (ADTX)|Cumulative Company Assets GRI Bio GRI|Total Business Assets XRTX (XORTX Therapeutics Inc)|ReShape Lifesciences (HIND) - Aggregate Company Assets|Total Asset Value of Company Revelation Biosciences Corp REVB|Company Total Assets Indaptus Therapeutics (INDP)|SCNI - Aggregate Asset Value|CALI: Company Total Assets|AFMD (Affimed N.V.) - Company Total Assets|ALLK - Aggregate Company Assets|Aggregate Asset Value HOOK|Aggregate Company Assets IGMS (IGM Biosciences, Inc.)|Cumulative Company Assets iteostherapeutics.com (ITOS)|Company Total Assets OCEA (Ocean Biomedical)|TCBP - Company Total Assets|Cumulative Company Assets Third Harmonic Bio, Inc (THRD)